Peramivir conjugates as orally available agents against influenza H275Y mutant

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12

Linda Reed, Hugo Muench · American Journal of Epidemiology · 1938 · 20.2K citations

Public Health, Health Sciences, Epidemiologic Methods +6

Re-emergence of fatal human influenza A subtype H5N1 disease

WC Yu, CW Leung, WF Ng et al. · The Lancet · 2004 · 817 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

Patrick Collins, L.F. Haire, Yi Pu Lin et al. · Nature · 2008 · 537 citations

Life Sciences, Infectious Diseases, Microbiology +14

BCX-1812 (RWJ-270201):  Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

Y.S. Babu, Pooran Chand, Shanta Bantia et al. · Journal of Medicinal Chemistry · 2000 · 378 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

Bo‐Jian Zheng, Kwok‐Wah Chan, Yongping Lin et al. · Proceedings of the National Academy of Sciences · 2008 · 304 citations

Veterinary Medicine, Immunology, Infectious Diseases +17